BioCryst Pharmaceuticals
BCRX
#4706
Rank
โ‚น135.96 B
Marketcap
โ‚น656.44
Share price
1.43%
Change (1 day)
57.26%
Change (1 year)

Revenue for BioCryst Pharmaceuticals (BCRX)

Revenue in 2024 (TTM): โ‚น31.83 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น32.25 Billion. In 2023 the company made a revenue of โ‚น27.58 Billion an increase over the revenue in the year 2022 that were of โ‚น22.41 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BioCryst Pharmaceuticals from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น31.83 B15.4%
2023 โ‚น27.58 B23.11%
2022 โ‚น22.41 B91.57%
2021 โ‚น11.69 B798.03%
2020 โ‚น1.30 B-62.59%
2019 โ‚น3.48 B141.15%
2018 โ‚น1.44 B-10.2%
2017 โ‚น1.60 B-10.2%
2016 โ‚น1.79 B-44.16%
2015 โ‚น3.20 B271.84%
2014 โ‚น0.86 B-19.45%
2013 โ‚น1.07 B-25.63%
2012 โ‚น1.43 B38.54%
2011 โ‚น1.03 B-62.83%
2010 โ‚น2.79 B-19.23%
2009 โ‚น3.46 B27.31%
2008 โ‚น2.71 B-2.76%
2007 โ‚น2.79 B916.33%
2006 โ‚น0.27 B3925.19%
2005 โ‚น6.83 M1672.84%
2004 โ‚น0.38 M-99.48%
2003 โ‚น74.39 M-12.57%
2002 โ‚น85.09 M-84.19%
2001 โ‚น0.53 B912.23%
2000 โ‚น53.18 M-54.57%
1999 โ‚น0.11 B-58.28%
1998 โ‚น0.28 B495.06%
1997 โ‚น47.15 M-49.55%
1996 โ‚น93.47 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น50.82 B 57.59%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น126.98 B 293.73%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น66.21 B 105.32%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.345 T 7,173.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.70 B-97.83%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.396 T 10,430.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น90.65 B 181.08%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA